Get the Stockscreener App
79.89
37.06%
21.63
Doximity Inc stock is traded at $79.89, with a volume of 7.07M.
It is up +37.06% in the last 24 hours and up +43.93% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
See More
Previous Close:
$58.26
Open:
$72.5
24h Volume:
7.07M
Relative Volume:
3.43
Market Cap:
$10.88B
Revenue:
$516.85M
Net Income/Loss:
$174.11M
P/E Ratio:
91.82
EPS:
0.87
Net Cash Flow:
$217.38M
1W Performance:
+35.11%
1M Performance:
+43.93%
6M Performance:
+213.14%
1Y Performance:
+191.42%
1-Day Range:
$71.50
$80.71
1-Week Range:
$56.01
$80.71
52-Week Range:
$22.96
$80.71
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SAN FRANCISCO
Compare DOCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
79.87 | 10.88B | 516.85M | 174.11M | 217.38M | 0.87 |
|
VEEV
Veeva Systems Inc
|
237.14 | 38.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
73.07 | 12.92B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
67.96 | 10.23B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
112.47 | 9.71B | 1.15B | 96.70M | -161.99M | 1.09 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
IBD 50's Doximity Rockets 34%, Breaking Out, After Another 'Pristine' Quarter - Yahoo! Voices
Doximity Inc (DOCS) Soars 31.34%: Unpacking the Q3 Earnings Call Highlights - RagingBull
Telehealth Platform Doximity Stock Soars as AI Boosts Performance - Investopedia
Doximity shares pop 30% on revenue beat, rosy guidance - NBC Boston
Deep Dive Into Doximity Stock: Analyst Perspectives (12 Ratings) - Benzinga
Doximity, Inc. (NYSE:DOCS) Q3 2025 Earnings Call Transcript - Insider Monkey
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Doximity’s Neutral Rating: Balancing Strong Q3 Performance with Cautious Future Outlook - TipRanks
IMMINENT DOCS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Doximity, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Earnings call transcript: Doximity Q3 FY2025 sees strong earnings beat - MSN
Doximity Surpasses EPS, Revenue Goals - MSN
IBD 50 Stock Doximity Rockets And Eyes A Breakout After Walloping Earnings Views - MSN
Doximity Reports Strong Q3 Financial Growth - TipRanks
Doximity earnings beat by $0.11, revenue topped estimates - Investing.com Canada
Doximity raises FY2025 revenue guidance by $28M amid strong Q3 performance - MSN
Trust Point Inc. Sells 13,551 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Director Timothy S. Cabral Sells 20,000 Shares - MarketBeat
Doximity (DOCS) Q3 Earnings and Revenues Top Estimates - Yahoo Canada Finance
Doximity shares soar 21% after company beats on revenue, raises fiscal-year guidance - NBC Philadelphia
Doximity (NYSE:DOCS) Reports Upbeat Q4, Stock Jumps 22.5% By Stock Story - Investing.com Canada
Doximity Fiscal Q3 Non-GAAP Earnings, Revenue Increase -- Shares Jump After Hours - Marketscreener.com
Doximity: Fiscal Q3 Earnings Snapshot - CTPost
Doximity Earnings Report: Q3 Overview - Benzinga
Doximity stock soars on strong earnings beat and upbeat outlook By Investing.com - Investing.com South Africa
Doximity stock soars on strong earnings beat and upbeat outlook - Investing.com India
Healthcare Leaders Crown Doximity as Top Telehealth Platform, Perfect Score Sweep in 2025 KLAS Report - StockTitan
Doximity Announces Fiscal 2025 Third Quarter Financial Results - StockTitan
Truist Securities Adjusts Doximity Price Target to $65 From $49, Maintains Hold Rating - Marketscreener.com
Doximity director Timothy Cabral sells $1.15 million in stock - MSN
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Retirement Systems of Alabama - MarketBeat
Doximity director Timothy Cabral sells $1.15 million in stock By Investing.com - Investing.com South Africa
Doximity Inc (DOCS) Stock Price Down 3.15% on Feb 5 - GuruFocus.com
Doximity (DOCS) Q4 Earnings: What To Expect - Yahoo Finance
What To Expect From Doximity Inc (DOCS) Q3 2025 Earnings - GuruFocus.com
Swedbank AB Cuts Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Shares Bought by KBC Group NV - MarketBeat
Baader Bank Aktiengesellschaft Raises Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity Holds Critical Levels In Sell-Off As Earnings Loom - MSN
Lebenthal Global Advisors LLC Invests $330,000 in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Smith Group Asset Management LLC - MarketBeat
Doximity to Release Fiscal 2023 First Quarter Results on August 4, 2022 - BioSpace
Pacer Advisors Inc. Buys 186,093 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (DOCS) Gains As Market Dips: What You Should Know - MSN
Lifestyle Asset Management Inc. Takes Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.82%
2.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):